Redmile Group, LLC Liva Nova PLC Transaction History

Redmile Group, LLC

$908 Million
Q3 2025

A detailed history of Redmile Group, LLC transactions in Liva Nova PLC stock. As of the latest transaction made, Redmile Group, LLC holds 926,799 shares of LIVN stock, worth $51.3 Million. This represents 5.35% of its overall portfolio holdings.

Number of Shares

926,799

Previous 934,271 0.8%

Holding current value

$51.3 Million

Previous $42.1 Million 15.42%

% of portfolio

5.35%

Previous 5.12%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	SELL	$41.13 - $58.72 $307,323 - $438,755	-7,472 Reduced 0.8%	926,799 $48.5 Million
Q2 2025 Aug 14, 2025	SELL	$33.85 - $47.6 $2.7 Million - $3.8 Million	-79,868 Reduced 7.88%	934,271 $42.1 Million
Q1 2025 May 15, 2025	SELL	$37.02 - $50.73 $1.09 Million - $1.49 Million	-29,400 Reduced 2.82%	1,014,139 $39.8 Million
Q4 2024 Feb 14, 2025	BUY	$45.7 - $53.85 $7.7 Million - $9.07 Million	168,500 Added 19.26%	1,043,539 $48.3 Million
Q3 2024 Nov 14, 2024	SELL	$43.38 - $54.59 $2.36 Million - $2.97 Million	-54,467 Reduced 5.86%	875,039 $45.9 Million

Q2 2024 Aug 14, 2024	SELL	$51.76 - $64.15 $5.6 Million - $6.95 Million	-108,274 Reduced 10.43%	929,506 $51 Million
Q1 2024 May 15, 2024	SELL	$48.6 - $57.12 $4.83 Million - $5.67 Million	-99,288 Reduced 8.73%	1,037,780 $58.1 Million
Q4 2023 Feb 14, 2024	BUY	$43.45 - $53.66 $1.59 Million - $1.96 Million	36,576 Added 3.32%	1,137,068 $58.8 Million
Q2 2023 Aug 14, 2023	SELL	$42.28 - $51.43 $3.63 Million - $4.42 Million	-85,926 Reduced 7.24%	1,100,492 $56.6 Million
Q1 2023 May 15, 2023	BUY	$40.84 - $58.14 $3.27 Million - $4.65 Million	80,009 Added 7.23%	1,186,418 $51.7 Million
Q4 2022 Feb 14, 2023	SELL	$43.88 - $56.16 $18.9 Million - $24.1 Million	-429,953 Reduced 27.99%	1,106,409 $61.4 Million
Q3 2022 Nov 14, 2022	SELL	$48.37 - $66.5 $4.23 Million - $5.81 Million	-87,400 Reduced 5.38%	1,536,362 $78 Million
Q2 2022 Aug 15, 2022	SELL	$57.25 - $86.63 $19.9 Million - $30 Million	-346,749 Reduced 17.6%	1,623,762 $101 Million
Q1 2022 May 16, 2022	SELL	$71.02 - $86.99 $6.16 Million - $7.54 Million	-86,667 Reduced 4.21%	1,970,511 $161 Million
Q4 2021 Feb 14, 2022	SELL	$76.72 - $92.68 $10.3 Million - $12.4 Million	-133,841 Reduced 6.11%	2,057,178 $180 Million
Q3 2021 Nov 15, 2021	BUY	$76.02 - $88.62 $82.1 Million - $95.7 Million	1,079,335 Added 97.09%	2,191,019 $174 Million
Q2 2021 Aug 16, 2021	SELL	$73.44 - $87.01 $598,242 - $708,783	-8,146 Reduced 0.73%	1,111,684 $93.5 Million
Q1 2021 May 17, 2021	BUY	$62.9 - $82.41 $70.4 Million - $92.3 Million	1,119,830 New	1,119,830 $82.6 Million
Q4 2019 Feb 14, 2020	SELL	$68.92 - $85.27 $23.6 Million - $29.2 Million	-342,987 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$71.74 - $86.35 $5.81 Million - $6.99 Million	-81,000 Reduced 19.1%	342,987 $25.3 Million
Q2 2019 Aug 14, 2019	SELL	$66.45 - $97.36 $10.5 Million - $15.5 Million	-158,700 Reduced 27.24%	423,987 $30.5 Million
Q1 2019 May 15, 2019	BUY	$86.15 - $100.49 $5.83 Million - $6.8 Million	67,700 Added 13.15%	582,687 $56.7 Million
Q4 2018 Feb 14, 2019	SELL	$84.14 - $125.42 $7.09 Million - $10.6 Million	-84,301 Reduced 14.07%	514,987 $47.1 Million
Q3 2018 Nov 14, 2018	SELL	$101.02 - $130.95 $50,510 - $65,474	-500 Reduced 0.08%	599,288 $74.3 Million
Q2 2018 Aug 14, 2018	BUY	$81.75 - $105.37 $6.66 Million - $8.59 Million	81,500 Added 15.72%	599,788 $59.9 Million
Q1 2018 May 15, 2018	SELL	$79.95 - $89.74 $7.78 Million - $8.73 Million	-97,300 Reduced 15.81%	518,288 $0
Q4 2017 Feb 14, 2018	SELL	$71.8 - $88.21 $1.21 Million - $1.49 Million	-16,900 Reduced 2.67%	615,588 $49.2 Million
Q3 2017 Nov 14, 2017	BUY	$60.32 - $70.06 $38.2 Million - $44.3 Million	632,488	632,488 $44.3 Million

Others Institutions Holding LIVN

# of Institutions

296

Shares Held

56.9M

Call Options Held

152K

Put Options Held

49.3K

View Full List

About LivaNova PLC

Ticker LIVN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 53,545,700
Market Cap $2.96B
Description
LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines,...

More about LIVN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Redmile Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Redmile Group, LLC with notifications on news.

Account

Redmile Group, LLC Liva Nova PLC Transaction History